iBio (IBIO)
(Delayed Data from AMEX)
$1.97 USD
+0.07 (3.68%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.89 -0.08 (-4.06%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for iBio, Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -65.01 | -50.30 | -23.21 | -16.44 |
Depreciation/Amortization & Depletion | NA | 1.69 | 4.21 | 2.63 | 2.24 |
Net Change from Assets/Liabilities | NA | 5.87 | 3.24 | -11.15 | 0.47 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 27.02 | 5.37 | 1.67 | 0.39 |
Net Cash From Operating Activities | NA | -30.44 | -37.48 | -30.06 | -13.35 |
Property & Equipment | NA | -3.14 | -7.33 | -4.92 | -1.08 |
Acquisition/ Disposition of Subsidiaries | NA | -0.69 | 0.00 | 0.00 | 0.00 |
Investments | NA | 10.84 | 6.50 | -19.82 | 0.00 |
Other Investing Activities | NA | 0.00 | -4.30 | -1.74 | -0.08 |
Net Cash from Investing Activities | NA | 7.01 | -5.13 | -26.48 | -1.15 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 11.45 | 0.08 | 78.33 | 68.82 |
Issuance (Repayment) of Debt | NA | -9.13 | -5.83 | -0.33 | 0.53 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | -2.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.02 | -0.37 | 0.84 | -2.17 |
Net Cash from Financing Activities | NA | 2.30 | -6.13 | 78.84 | 65.19 |
Effect of Exchange Rate Changes | NA | 0.03 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -21.09 | -48.73 | 22.29 | 50.69 |
Cash at Beginning of Period | NA | 28.67 | 77.40 | 55.11 | 4.42 |
Cash at End of Period | NA | 7.58 | 28.67 | 77.40 | 55.11 |
Diluted Net EPS | NA | -106.20 | -115.60 | -60.00 | -305.00 |
Fiscal Year End for iBio, Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -17.13 | -13.96 | -5.75 | -65.01 |
Depreciation/Amortization & Depletion | NA | 1.09 | 0.76 | 0.41 | 1.69 |
Net Change from Assets/Liabilities | NA | -0.92 | -0.82 | -0.70 | 5.87 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.26 | 3.97 | 0.69 | 27.02 |
Net Cash From Operating Activities | NA | -13.70 | -10.05 | -5.34 | -30.44 |
Property & Equipment | NA | 0.05 | 0.05 | 0.05 | -3.14 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | -0.69 |
Investments | NA | 0.00 | 0.00 | 0.00 | 10.84 |
Other Investing Activities | NA | 1.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 1.05 | 0.05 | 0.05 | 7.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 11.28 | 7.01 | 2.90 | 11.45 |
Issuance (Repayment) of Debt | NA | 0.10 | -0.65 | -0.54 | -9.13 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.12 | 0.12 | 0.12 | -0.02 |
Net Cash from Financing Activities | NA | 11.50 | 6.48 | 2.47 | 2.30 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.03 |
Net Change In Cash & Equivalents | NA | -1.15 | -3.52 | -2.82 | -21.09 |
Cash at Beginning of Period | NA | 7.58 | 7.58 | 7.58 | 28.67 |
Cash at End of Period | NA | 6.43 | 4.06 | 4.76 | 7.58 |
Diluted Net EPS | NA | -0.85 | -4.42 | -4.80 | 14.20 |